The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC)

Prof Moji Adeyeye

Prof Moji Adeyeye is the Director General of the National Agency for Food and Drug Administration and Control (NAFDAC) where she has added strong governance structure, regulatory system strengthening, and strengthening of the local pharmaceutical companies through international best practices with emphasis on local manufacturing.


Prof Moji Adeyeye has brought NAFDAC from insolvency to solvency and refocused the Agency to be a Standard Operating Procedure-driven organization that has embraced international standards and best practices.

She changed the culture of NAFDAC to a Customer-focused and Agency-minded establishment in order to safeguard the health of the nation. All these have resulted in the attainment of ISO 9001-2015 in 2019, yearly re-certification, and WHO Maturity Level 3 (ISO 9004) in 2022, as recognition as a well-functioning Agency. 

Consequent to this is the gradual strengthening of the pharmaceutical industry as exemplified in the recent WHO prequalification of a pediatric product of a local manufacturer, the first in West and Central Africa.

The paradigm shift for access to medicines included the introduction of innovative reforms such as the 5+5 policy, the expansion of NAFDAC’s ceiling list to thirty-four (34) products (aimed at increasing access to quality medicine through local manufacturing), a new policy on the establishment of Pharmaceutical Plants in Nigeria, the centralized GMP inspection for Pharma plants and Good Distribution Practice (GDP) inspection.

The ongoing transformative leadership is reflected in the strengthening of grassroots pharmacovigilance or post-marketing safety monitoring, expansion of risk-based post-marketing surveillance, the introduction of a Dossier Management System (an online solution that streamlines the dossier), leading in Africa the development and use of Traceability Information System – a GS1-driven technology – to give COVID-19 vaccines and ATM commodities’ supply chain visibility and mitigate substandard and falsified medicines, as part of restructuring toward  ML4 and WLA status.

She leads the Agency in strengthening the Food industry in the Agency through an emphasis on Food Safety, evidence-based Chemicals and Pesticides Management.  She inaugurated the Nigerian Herbal Medicine Product Committee (HMPC) as a means of fostering research involving herbal practitioners and academic researchers while intellectual property is protected. The ultimate goal is to turn complementary alternative medicines into research-driven, regulation-controlled commercially viable commodities.

She is the past Chair of the Steering Committee of the African Medicines Regulatory Harmonization (AMRH) and the WHO-based Global Pediatric Regulatory Network. She represents NAFDAC on the International Coalition of Medicines Regulatory Authorities (ICMRA) and has been invited to be on the WHO Regional Expert Advisory Committee on Traditional Medicine for COVID-19.   She is a Fellow of Nigeria Academy of Science, Nigeria Academy of Pharmacy, an Academic Research Fellow of the American Association of Colleges of Pharmacy (AACP). She is the First African Woman Fellow, the American Association of Pharmaceutical Scientists (AAPS) a society where only 3% of academia receives such recognition internationally.

She is a Professor Emeritus of Pharmaceutics and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois, USA.  Professor Adeyeye was the founding Chair of Biopharmaceutical Sciences at the same University in Illinois. She was a Professor of Pharmaceutics and Manufacturing for twenty-one (21) years at Duquesne University in Pittsburgh, PA, USA.   She is a Senior Fulbright Scholar and Specialist. She earned her B.Sc. from the University of Nigeria, Nsukka, Nigeria and her MS and PhD from the University of Georgia, Athens, GA. Her research interests include quality-by-design (QbD) early-phase development and the manufacturing of solid, semi-solid and liquid dosage forms, including Investigation of New Drug Application (IND)-based late phase manufacturing.  She is an expert in research and drug development (R&D), bench-to-bedside translational research and regulatory science. She has mentored over 15 PhD and M.S candidates.

She has 5 patents, 65 peer-reviewed manuscripts, book chapters and books, and more than 160 scientific presentations.


At Nigerian Books of Record, we keep track of record breakers, impact makers, and change agents. We aim at documenting, celebrating, and honoring the remarkable achievements and excellent records of people.

By honouring new generations of game changers and sharing their authentic stories, we aim to break boundaries, entertain, inspire, and inform the world.

Books of Record will always strive to encourage, find, and share the uniqueness in every achiever that has distinguished themselves through hard work in every professional calling of life.

Always visit this platform for the latest update on any of our inductions. Send us an email for suggestions on how we can serve you better or suggestions on the next NBR Hall of Famer.

Advertise with us here.

Please, follow Nigerian Books of Record on Facebook, Instagram and Twitter.

1 Comment

  1. Insightful and well-written! Your points are thought-provoking. For those wanting to learn more about this topic, here’s a great resource: FIND OUT MORE. Interested in hearing everyone’s perspective!

Leave a Reply

Your email address will not be published.